Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Catalyst commences enrollment for U.S. phase II CPP-109 trial in addiction

July 1, 2008

Alkermes initiates phase III Vivitrol study for opioid dependence

June 27, 2008

US WorldMeds reports initial results from phase III clinical trial of lofexidine

June 19, 2008

Novartis launches oral iron-chelating agent Exjade for chronic iron overload in Japan

June 16, 2008

Targacept designates neuronal nicotinic receptor drug in smoking cessation program

May 7, 2008

DOR BioPharma initiates nonhuman primate efficacy studies of RiVax ricin toxin vaccine

May 2, 2008

Independent Pharmaceutica initiates phase II clinical trial of Niccine for nicotine dependence

April 30, 2008

Champix set for Japanese launch

April 22, 2008

Novartis receives approval for Exjade in Japan

April 18, 2008

Modafinil improves cocaine abstinence in some addicted patients

April 9, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...